Karim Mikhail, acting CBER director, has just been named the permanent branch leader. Karim Mikhail is permanent CBER director, unusual background Most people in the field want more stability and logic-based decision-making.
Karim Mikhail, acting CBER director, has just been named the permanent branch leader.
Karim Mikhail is permanent CBER director, unusual background Most people in the field want more stability and logic-based decision-making.
What might this mean for the cell and gene therapy field?
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
Karim Mikhail, acting CBER director, has just been named the permanent branch leader. Karim Mikhail is permanent CBER director, unusual background Most people in the field want more stability and logic-based decision-making. What might this mean for the cell and gene therapy field?
What might this mean for the cell and gene therapy field? For instance, if CBER is going to be more flexible, that flexibility […]
Open the app view to save this story, compare related coverage, and continue from the same source.